Home
PB Ratio of Venmax Drugs & Pharmaceuticals Ltd

Venmax Drugs & Pharmaceuticals Ltd
NSE: VENMAXDRUGS
PB Ratio
Key Highlights
- The latest PB Ratio of Venmax Drugs & Pharmaceuticals Ltd is 3.3.
- The PB ratio of the Venmax Drugs & Pharmaceuticals Ltd is above 3 which indicates that the stock is overvalued but this is common in high-growing sectors.
- The P/B Ratio of Venmax Drugs & Pharmaceuticals Ltd changed from -22.6 on March 2025 to -22.6 on March 2025 . This represents a CAGR of 0.00% over 1 years.
Historical P/B Ratio of Venmax Drugs & Pharmaceuticals Ltd
The price-to-book (P/B) ratio compares a company's market capitalization to its book value by dividing its stock price per share by its book value per share. How to calculate Price-to-Book (P/B) Ratio? The Price-to-Book Ratio is used to determine the relationship between the total value of a company's outstanding shares and the net value of its assets. Before calculating the P/B ratio, investors need to overlook the market capitalization of a company. Market capitalization = market value of a stock X no. of outstanding shares Now, you need to know the net value of an organization's assets. Book Value of Assets = Total Assets - Total Liabilities of a company After knowing the value of the above ratios, here is the formula for the P/B Ratio: P/B Ratio = Market Capitalization/ Book Value of Assets or you can also use this formula P/B ratio = Market Price Per Share/ Book Value of Asset Per Share
Historical P/B Ratio of Venmax Drugs & Pharmaceuticals Ltd
Company Fundamentals for Venmax Drugs & Pharmaceuticals Ltd
Market Cap
14 Cr
EPS
0.0
P/E Ratio (TTM)
0.0
P/B Ratio (TTM)
3.3
Day’s High
27.37
Day’s Low
25.88
DTE
0.0
ROE
0.4
52 Week High
36.96
52 Week Low
6.27
ROCE
0.3
Market Price of Venmax Drugs & Pharmaceuticals Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
| Date | |
|---|---|
| 30 Oct 2025 | 27.19 | 
| 29 Oct 2025 | 26.07 | 
| 28 Oct 2025 | 26.91 | 
| 27 Oct 2025 | 28.25 | 
| 24 Oct 2025 | 29.71 | 
| 23 Oct 2025 | 28.4 | 
| 21 Oct 2025 | 27.05 | 
| 20 Oct 2025 | 25.77 | 
| 17 Oct 2025 | 25.44 | 
| 16 Oct 2025 | 24.23 | 
SWOT Analysis Of Venmax Drugs & Pharmaceuticals Ltd
BlinkX Score for Venmax Drugs & Pharmaceuticals Ltd
Asset Value vs Market Value of Venmax Drugs & Pharmaceuticals Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of P/B Ratio
| Company | PB | Market Cap | 
|---|
| Venmax Drugs & Pharmaceuticals Ltd | 3.25 | 14.25 | 
| Sun Pharmaceutical Industries Ltd | 101.4 | 408751 | 
| Divis Laboratories Ltd | 561.1 | 176634 | 
| Cipla Ltd | 411.6 | 124437 | 
| Torrent Pharmaceuticals Ltd | 224.3 | 121865 | 
| Company | |
|---|---|
| Venmax Drugs & Pharmaceuticals Ltd | 3.25 | 
| Sun Pharmaceutical Industries Ltd | 101.4 | 
| Divis Laboratories Ltd | 561.1 | 
| Cipla Ltd | 411.6 | 
| Torrent Pharmaceuticals Ltd | 224.3 | 
PB Ratio of Venmax Drugs & Pharmaceuticals Ltd Explained
₹14.25
Market cap
₹8
Book Value per Share
3.3X
PB Ratio
Historical Market Cap of Venmax Drugs & Pharmaceuticals Ltd
Market Cap or market capitalisation refers to metrics that are used to measure a company's size. It is defined as the total market value of a company's outstanding shares of stock. Formula of Market Cap: Market Capital = N * P Here, N for the outstanding shares P refers to the closing price of the company's shares. Types of Companies based on Market Cap: - Small-Cap stocks: Up to 500 Crore - Mid-Cap Stocks: From Rs.500 crore up to Rs.7,000 crore - Large-Cap Stocks: From Rs.7,000 crore up to Rs.20,000 crore
Historical Market Cap of Venmax Drugs & Pharmaceuticals Ltd
Market Cap
Historical Revenue, EBITDA and Net Profit of Venmax Drugs & Pharmaceuticals Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Revenue, EBITDA and Net Profit of Venmax Drugs & Pharmaceuticals Ltd
Revenue
EBITDA
Net Profit
Dividend Payout Over Time
Venmax Drugs & Pharmaceuticals Ltd News Hub
Venmax Drugs & Pharmaceuticals to conduct board meeting
Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 22 Au
Read more
16 Aug 24
Venmax Drugs & Pharmaceuticals standalone net profit declines 50.00% in the June 2024 quarter
Net profit of Venmax Drugs & Pharmaceuticals declined 50.00% to Rs 0.01 crore in the quarter ended J
Read more
13 Aug 24
Venmax Drugs & Pharmaceuticals to hold board meeting
Venmax Drugs & Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 12 Au
Read more
03 Aug 24
Venmax Drugs & Pharmaceuticals to hold AGM
Venmax Drugs & Pharmaceuticals announced that the 35th Annual General Meeting (AGM) of the company w
Read more
27 Aug 24
